Publication:
Editorial: Antivirulence Drugs Against Bacterial Infections.

Simple item page
dc.contributor.authorImperi, Francesco
dc.contributor.authorChen, Wangxue
dc.contributor.authorSmani, Younes
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderSubprograma Miguel Servet Tipo I, Instituto de Salud Carlos III of Spain
dc.contributor.funderExcellence Departments grant from the Italian Ministry of Education, University and Research
dc.date.accessioned2023-02-09T11:40:23Z
dc.date.available2023-02-09T11:40:23Z
dc.date.issued2021-05-25
dc.description.abstractAntimicrobial resistance poses a well-recognized public health threat worldwide due to the global dissemination of bacteria resistant to multiple antibiotic classes and the development of severe infections such as bacteremia , pneumonia , urinary tract , and intraabdominal infections .
dc.description.versionSi
dc.identifier.citationImperi F, Chen W, Smani Y. Editorial: Antivirulence Drugs Against Bacterial Infections. Front Microbiol. 2021 May 25;12:690672.
dc.identifier.doi10.3389/fmicb.2021.690672
dc.identifier.issn1664-302X
dc.identifier.pmcPMC8186663
dc.identifier.pmid34113335
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186663/pdf
dc.identifier.unpaywallURLhttps://www.frontiersin.org/articles/10.3389/fmicb.2021.690672/pdf
dc.identifier.urihttp://hdl.handle.net/10668/17988
dc.journal.titleFrontiers in microbiology
dc.journal.titleabbreviationFront Microbiol
dc.language.isoen
dc.organizationInstituto de Biomedicina de Sevilla-IBIS
dc.organizationHospital Universitario Virgen del Rocío
dc.page.number3
dc.provenanceRealizada la curación de contenido 04/04/2025
dc.publisherFrontiers Research Foundation
dc.pubmedtypeEditorial
dc.relation.projectIDPI19/01009
dc.relation.projectIDCP15/00132
dc.relation.projectID314337
dc.relation.projectID232/2016
dc.relation.publisherversionhttps://doi.org/10.3389/fmicb.2021.690672
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectantivirulence
dc.subjectbacteria
dc.subjectdrug
dc.subjectinfection
dc.subjecttreatment
dc.subject.decsSalud Pública
dc.subject.decsBacterias
dc.subject.decsInfecciones
dc.subject.decsBacteriemia
dc.subject.decsSistema Urinario
dc.subject.decsAntibacterianos
dc.subject.decsNeumonía
dc.subject.decsInfecciones intraabdominales
dc.subject.meshAnti-Bacterial Agents
dc.subject.meshPublic Health
dc.subject.meshDrug Resistance, Bacterial
dc.subject.meshBacteria
dc.subject.meshBacteremia
dc.subject.meshPneumonia
dc.subject.meshUrinary Tract
dc.subject.meshIntraabdominal Infections
dc.titleEditorial: Antivirulence Drugs Against Bacterial Infections.
dc.typeEditorial
dc.type.hasVersionVoR
dc.volume.number12
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
PMC8186663.pdf
Size:
105.67 KB
Format:
Adobe Portable Document Format
Download

Collections

SAS - Hospital Universitario Virgen del Rocío
Instituto de Investigación Biomédica de Sevilla (IBIS)

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía